111 related articles for article (PubMed ID: 31328487)
1. [Pilot-scale preparation of clinical-grade third generation lentivirus].
Duan D; Ji Y; Zhou M; Gao J
Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1307-1316. PubMed ID: 31328487
[TBL] [Abstract][Full Text] [Related]
2. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
[TBL] [Abstract][Full Text] [Related]
3. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
4. Optimized Transgene Delivery Using Third-Generation Lentiviruses.
Gill KP; Denham M
Curr Protoc Mol Biol; 2020 Dec; 133(1):e125. PubMed ID: 32986282
[TBL] [Abstract][Full Text] [Related]
5. Generation of lentivirus vectors using recombinant baculoviruses.
Lesch HP; Turpeinen S; Niskanen EA; Mähönen AJ; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2008 Sep; 15(18):1280-6. PubMed ID: 18463689
[TBL] [Abstract][Full Text] [Related]
6. Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction.
Toran PT; Wohlfahrt M; Foye J; Kiem HP; Wojchowski DM
Exp Hematol; 2020 Jun; 86():28-42.e3. PubMed ID: 32473295
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of lentivirus containing human FcγRIIB gene and FcγRIIB expression in HT-1080 cells].
Liu H; Cao X; Yang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):561-4, 568. PubMed ID: 24909272
[TBL] [Abstract][Full Text] [Related]
8. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
[TBL] [Abstract][Full Text] [Related]
9. Transient Lentiviral Vector Production Using a Packed-Bed Bioreactor System.
McCarron A; Donnelley M; McIntyre C; Parsons D
Hum Gene Ther Methods; 2019 Jun; 30(3):93-101. PubMed ID: 31084376
[TBL] [Abstract][Full Text] [Related]
10. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Gama-Norton L; Botezatu L; Herrmann S; Schweizer M; Alves PM; Hauser H; Wirth D
Hum Gene Ther; 2011 Oct; 22(10):1269-79. PubMed ID: 21554103
[TBL] [Abstract][Full Text] [Related]
12. Generation of lentiviral vectors for use in skeletal muscle research.
Pichavant C; Tremblay JP
Methods Mol Biol; 2012; 798():285-95. PubMed ID: 22130843
[TBL] [Abstract][Full Text] [Related]
13. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
14. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
15. Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice.
Gándara C; Affleck V; Stoll EA
Hum Gene Ther Methods; 2018 Feb; 29(1):1-15. PubMed ID: 29212357
[TBL] [Abstract][Full Text] [Related]
16. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
17. Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.
van der Loo JC; Swaney WP; Grassman E; Terwilliger A; Higashimoto T; Schambach A; Baum C; Thrasher AJ; Williams DA; Nordling DL; Reeves L; Malik P
Gene Ther; 2012 Mar; 19(3):246-54. PubMed ID: 21753795
[TBL] [Abstract][Full Text] [Related]
18. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.
Cornetta K; Duffy L; Turtle CJ; Jensen M; Forman S; Binder-Scholl G; Fry T; Chew A; Maloney DG; June CH
Mol Ther; 2018 Jan; 26(1):280-288. PubMed ID: 28970045
[TBL] [Abstract][Full Text] [Related]
19. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
20. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
